Real-time enrollment status for this high-grade glioma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:52 AM UTC
| NCT Number | NCT06829173 |
| Recruiting Status | Recruiting |
| Condition | High-Grade Glioma |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 39 participants |
| Active Locations | 1 sites in the US |
| Sponsor | NYU Langone Health |
| Last Updated on CT.gov | January 2, 2026 (Jan 2, 2026) |
As of July 17, 2026: Clinical trial NCT06829173 is currently recruiting participants. This early_phase1 study for high-grade glioma is actively seeking new participants at 1 location across the United States. The study is sponsored by NYU Langone Health. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06829173 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06829173 was last updated Jan 2, 2026 (January 2, 2026). HelloStudys verifies this status automatically.